Drug repurposing for rare diseases
Healx has raised €105M across 4 funding rounds from 5 investors, most recently a round in Aug 2024. Based in Milton, UK; founded 2014; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-08-01 | Other | €44M | Atomico,R42 Group | View deal → |
| 2019-10-01 | Series B | €51M | Atomico | View deal → |
| 2018-07-18 | Series A | €8.5M | Amadeus Capital,Balderton Capital | View deal → |
| 2016-10-01 | Series A | €1.3M | Amadeus Capital Partners | View deal → |
